Harding Jessica L, Gompers Annika, Di Mengyu, Drewery Kelsey, Pastan Stephen, Rossi Ana, DuBay Derek, Gander Jennifer C, Patzer Rachel E
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Kidney Int Rep. 2024 Apr 15;9(7):2134-2145. doi: 10.1016/j.ekir.2024.04.025. eCollection 2024 Jul.
Sex/gender inequities persist in access to kidney transplantation. Whether differences in preemptive referral (i.e., referral before dialysis start) explain this inequity remains unknown.
All adults (aged 18-79 years; = 44,204) initiating kidney replacement therapy (KRT; dialysis or transplant) in Georgia (GA), North Carolina (NC), or South Carolina (SC) between 2015 and 2019 were identified from the United States Renal Data System (USRDS). Individuals were linked to the Early Steps to Kidney Transplant Access Registry (E-STAR) to obtain data on preemptive referral and followed-up with through November 13, 2020, for outcomes of waitlisting and living donor transplant. Logistic regression assessed the association between sex/gender and likelihood of preemptive referral among all KRT patients. Cox-proportional hazards assessed the association between sex/gender and waitlisting or living donor among preemptively referred patients.
Overall, men and women were similarly likely to be preemptively referred (odds ratio [OR]: 0.99 [0.95-1.04]). Preemptively referred women (vs. men) were, on average, younger and with fewer comorbidities. There were no sex/gender differences in waitlisting once patients were preemptively referred (hazard ratio [HR]: 0.97 [0.91-1.03]); however, women (vs. men) who were preemptively referred remained 25% (HR: 0.75 [0.66-0.86]) less likely to receive a living donor transplant.
In the Southeast US, men and women initiating KRT are similarly likely to be preemptively referred for a kidney transplant, and this appears, at least in part, to mitigate known sex/gender inequities in access to waitlisting, but not living donor transplant. Despite this, preemptively referred women, on average, had a more favorable medical profile relative to preemptively referred men.
在肾脏移植的获取方面,性别不平等现象依然存在。预防性转诊(即在开始透析前转诊)的差异是否能解释这种不平等尚不清楚。
从美国肾脏数据系统(USRDS)中确定了2015年至2019年间在佐治亚州(GA)、北卡罗来纳州(NC)或南卡罗来纳州(SC)开始肾脏替代治疗(KRT;透析或移植)的所有成年人(年龄在18 - 79岁;n = 44,204)。将个体与肾脏移植获取早期步骤登记处(E - STAR)关联,以获取预防性转诊数据,并随访至2020年11月13日,了解等待名单和活体供体移植的结果。逻辑回归评估了所有KRT患者的性别与预防性转诊可能性之间的关联。Cox比例风险模型评估了预防性转诊患者的性别与等待名单或活体供体之间的关联。
总体而言,男性和女性被预防性转诊的可能性相似(优势比[OR]:0.99[0.95 - 1.04])。被预防性转诊的女性(与男性相比)平均年龄更小,合并症更少。一旦患者被预防性转诊,在等待名单方面没有性别差异(风险比[HR]:0.97[0.91 - 1.03]);然而,被预防性转诊的女性(与男性相比)接受活体供体移植的可能性仍然低25%(HR:0.75[0.66 - 0.86])。
在美国东南部,开始KRT的男性和女性被预防性转诊进行肾脏移植的可能性相似,这似乎至少在一定程度上减轻了已知的在进入等待名单方面的性别不平等,但在活体供体移植方面并非如此。尽管如此,被预防性转诊的女性相对于被预防性转诊的男性,平均而言具有更有利的医疗状况。